Is Durrant getting an even bigger bang for his drug development bucks? I like the fact that Dale sold his Baudax shares, but that Intracoastal bought shares in the same time period. Will this present an opportunity for us regarding Tera-Immune?
Much more importantly, I see where Novavax announced today that they have entered into a Settlement Agreement with Gavi, regarding an Advanced Purchase Agreement.
The event that I am most looking forward to is the recall of our loaned shares, which may give me a brief moment to sell shares into a short squeeze.
But, the potential partnership that I am most looking forward to would be a stock-for-stock transaction with Novavax in a merger or business combination. I think that could lead to sustained annual revenue of over $67 per share, giving us a Market Cap in the $8B range.
The Gavi settlement greatly improves the outlook for Novavax to survive, and I hope it will prove another of the requirements for Humanigen to proceed with this venture (the first requirement was to significantly reduce R&D expense, which they have done). With the current institutional interest in Novavax, I am very excited about a possible pending announcement about a partnership with us.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.